Charles Explorer logo
🇬🇧

Follow-up after the treatment of ovarian cancer - really without Ca 125?

Publication at First Faculty of Medicine |
2012

Abstract

Author expresses the opinion of the sustained role of CA125 monitoring with potential benefit for the subgroup of patients with solitary or operable recurrence or new treatment options.